What are some of the social determinants that can impact patient outcomes? Joining Dr. Anisha Dua to share strategies to improve these inequities are Dr. Grace Wright and Dr. Irene Blanco.

Drs. Dua, Blanco, and Wright are Novartis consultants.

194889 4/22

Shared treatment decisions can help guide patient care—but how can we implement them in our practice? Drs. Jason Liebowitz and Michael Putman share tips and strategies to implement shared decision-making (SDM) in rheumatology.

Dr. Liebowitz and Dr. Putman are Novartis consultants.

194889 4/22

Patients with spondyloarthritis, or SpA for short, can be at an increased cardiovascular risk.1,2 To learn how we can better understand and manage this risk, Dr. Anisha Dua is joined by Dr. Elaine Husni from the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Dr. Dua and Dr. Husni are Novartis consultants.

1. Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatol (United Kingdom). 2020;59:iv47-iv57.
2. Papagoras C, Markatseli TE, Saougou I, et al. Cardiovascular risk profile in patients with spondyloarthritis. Jt Bone Spine. 2014;81(1):57-63.

196466 6/22

From the approval of an HPV test with extended genotyping to the role of the NCI Risk Matrix, what do we need to know about the ASCCP Risk-Based Management Consensus Guidelines, and how will these updates impact the treatment pathways we recommend to our patients being screening for cervical cancer? Dr. Jeffery Andrews shares guideline recommendations and updates.

Social media is often used as a tool to network and connect to people around the world—but can rheumatologists use it to connect with their patients? Drs. Jason Liebowitz and Michael Putman share how rheumatologists can use it to improve care.

Dr. Liebowitz and Dr. Putman are Novartis consultants.

194889 4/22

What are some ways we can improve diversity in our workforce? Joining Dr. Anisha Dua to share how clinicians can make the workforce more inclusive are Dr. Grace Wright and Dr. Irene Blanco.

Drs. Dua, Blanco, and Wright are Novartis consultants.

194889 4/22

It's well understood that annual vaccination is the best way to help reduce the high burden associated with influenza. And while most influenza vaccines available in the United States are produced in eggs, this presents some inherent challenges, which can lead to reduced vaccine effectiveness. Fortunately, alternative production processes can help us overcome those challenges, and to learn more, Dr. Jennifer Caudle speaks with Dr. Wendy Wright and Dr. Gary Marshall.

USA-CRP-22-0018 May 2022

HER2 (ERBB2) mutations may increase receptor internalization and lead to hyperactive downstream signaling, uncontrolled cell growth, and tumorigenesis. Learn more about how HER2 mutations affect several types of cancer, including non-small cell lung cancer (NSCLC).

Intended for US Healthcare Professions only

©2022 Daiichi Sankyo, Inc. and AstraZeneca. PP-US-8201a-1332 06/22

As evidence-based medicine (EBM) continues to evolve, what do rheumatologists need to know to keep up? Drs. Jason Liebowitz and Michael Putman dive into EBM and its role in the field of rheumatology.

Dr. Liebowitz and Dr. Putman are Novartis consultants.

194889 4/22

How can we improve representation in rheumatology clinical trials? To share strategies, Dr. Anisha Dua joins Dr. Grace Wright and Dr. Irene Blanco to discuss diversity in clinical trials.

Drs. Dua, Blanco, and Wright are Novartis consultants.

194889 4/22